Meet Phillip and Darnell, both of whom have been diagnosed with coronary artery disease (CAD). How would you treat these two patients? Find out in this virtual simulation led by Dr Matthew Casey Becker that reviews key clinical considerations for the use of XARELTO® plus aspirin in patients who have been diagnosed with CAD.
This promotional educational activity is brought to you by Janssen Pharmaceuticals, Inc., and is not certified for continuing medical education. The consultant is a paid speaker for Janssen Pharmaceuticals, Inc. The speaker is presenting on behalf of Janssen and must present information in compliance with FDA requirements applicable to Janssen.
© Janssen Pharmaceuticals, Inc. 2022 07/22 cp-296921v1